Angadi VM, Jindal A. Methylene blue in septic shock—A novel weapon in our Arsenal: Are utility studies highlighting its futility? Indian J Crit Care Med 2024;28(1):89.
Shi R, Hamzaoui O, De Vita N, Monnet X, Teboul JL. Vasopressors in septic shock: Which, when, and how much? Ann Transl Med 2020;8(12):794. DOI: 10.21037/atm.2020.04.24.
Lahiry S, Thakur S, Chakraborty DS. Advances in vasodilatory shock: A concise review. Indian J Crit Care Med 2019;23(10):475–480. DOI: 10.5005/jp-journals-10071-23266.
Andersen LW, Mackenhauer J, Roberts JC, Berg KM, Cocchi MN, Donnino MW. Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc 2013;88(10):1127–1140. DOI: 10.1016/j.mayocp.2013.06.012.
Lee SM, An WS. New clinical criteria for septic shock: Serum lactate level as new emerging vital sign. J Thorac Dis 2016;8(7):1388–1390. DOI: 10.21037/jtd.2016.05.55.
Luis-Silva F, Menegueti MG, Sepeda CDR, Petroski-Moraes BC, Sato L, Peres LM, et al. Effect of methylene blue on hemodynamic and metabolic response in septic shock patients. Medicine (Baltimore) 2022;101(3):e28599. DOI: 10.1097/MD.0000000000028599.
Ibarra-Estrada M, Kattan E, Aguilera-González P, Sandoval-Plascencia L, Rico-Jauregui U, Gómez-Partida CA, et al. Early adjunctive methylene blue in patients with septic shock: A randomized controlled trial. Crit Care 2023;27(1):110. DOI: 10.1186/s13054-023-04397-7.
